GEBKIM Manufacturing Facility

GEBKIM Manufacturing Facility

Our manufacturing facility, whose foundations were laid in 2012, became operational at the end of 2015 with an investment exceeding EUR 150 million. Located in Dilovası GEBKİM Organized Industrial Zone, the facility spans a total area of 80,000 m², including 44,000 m² of enclosed production space.

All production and laboratory equipment used in our new facility consist of advanced technology systems from leading global brands in the pharmaceutical industry. In addition, the facility areas, architectural design, technical infrastructure, and equipment have been planned, established, and operated in full compliance with all applicable cGxP practices (cGMP, cGLP, cGDP, etc.).

All generated, produced, and processed data are securely stored in accordance with international data integrity principles using appropriate hardware, infrastructure, and software systems. Data integrity, traceability, accessibility, and continuity of recovery are fully ensured. Following its inauguration, our GEBKİM Manufacturing Facility received its manufacturing license and GMP (Good Manufacturing Practices) certificate from the Ministry of Health of the Republic of Türkiye in June 2015 and has successfully maintained these approvals in subsequent inspection cycles, most recently in March 2025.

Similarly, in November 2016, the GEBKİM facility obtained its first EU-GMP (European Union Good Manufacturing Practice) certification and has successfully completed subsequent certification processes in 2019, 2022, and most recently in 2025.

In line with our vision of becoming a reference company that combines local needs in global markets with international standards in the healthcare sector, our company continues its operations by prioritizing high-quality standards and a sustainable quality approach. Our competence in complying with international regulations was once again successfully demonstrated in 2025.

Within this scope, GMP certification processes conducted by ANVISA and DIGEMID authorities for the LATAM (Latin America) market, as well as inspections by the Russian health authority within the EAEU region, have been successfully completed. In addition, as of 2026, the GMP certification process by the Kazakhstan health authority has also been successfully finalized.

As Santa Farma, we continue our efforts to obtain ISO 9001, ISO 14001, and OHSAS 18001 certifications. In parallel with leading global companies, a Data Integrity system has been implemented within our operations. Our facility has successfully passed numerous inspections by international authorities in this field.

Santa Farma GEBKİM Manufacturing Facility has a production capacity of 150 million boxes per year on a single-shift basis. The facility is capable of producing a wide range of pharmaceutical forms, with batch sizes ranging from 15 to 1,000 kg for solid forms, 100 to 1,250 kg for semi-solid forms, and 400 to 13,000 liters for liquid forms.

With its modern facility and high-quality approach, Santa Farma aims to provide best-in-class contract manufacturing services and to become one of the most trusted and preferred partners in both local and international pharmaceutical markets. By embracing the principles of customer satisfaction, uncompromised trust, and transparency, Santa Farma ensures effective and efficient communication and process management from the agreement phase through to product transfer. Thanks to the combination of high-standard facilities and an experienced technical team, companies that prefer contract manufacturing can focus on their core operations such as sales and marketing, while achieving significant cost advantages.

Pellet production is also available at Santa Farma Manufacturing Facilities.
All semi-finished products are packaged without manual intervention on fully automated packaging lines equipped with electronic control systems capable of detecting defective or missing products and packaging materials. All packaging lines are integrated with weight control and serialization systems.